- ►annals.org [PDF] D Sources, D Synthesis - Ann Intern Med, 2003 - reference.com Background: Nicotinic acid is an effective treatment for dyslip- idemia, but the
content of over-the-counter niacin is not federally regulated. As a result,
patients may use preparations of over-the- counter niacin that do not ... Cited by 48 - Related articles - All 5 versions
CD Meyers, ML Kashyap - Endocrinology and metabolism clinics of North America, 2004 - Elsevier Characterized by insulin resistance, hypertension, abdominal obesity, and
specific lipid abnormalities, the metabolic syndrome is emerging as a major
cause of cardiovascular disease (CVD) and death in the Western world. ... Cited by 15 - Related articles - BL Direct - All 3 versions
RW Piepho - The American journal of cardiology, 2000 - Elsevier Bile acid sequestrants, fibric acid derivatives (fibrates),
hydroxy-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors
(“statins”), and niacin are able to increase HDL-C serum concentrations ... Cited by 47 - Related articles - BL Direct - All 7 versions
RH Knopp… - Metabolism, 1998 - Elsevier This study compared the efficacy and safety of a once-a-night, time-release
niacin formulation, Niaspan (Kos Pharmaceuticals, Miami Lakes, FL), with plain
niacin and placebo for the treatment of primary hypercholesterolemia. The ... Cited by 170 - Related articles - BL Direct - All 5 versions
JM McKenney, JD Proctor, S Harris, VM … - Jama, 1994 - Am Med Assoc OBJECTIVE--To compare escalating doses of immediate-release (IR) and
sustained-release (SR) niacin for effectiveness in reducing levels of
low-density lipoprotein cholesterol and triglycerides and increasing levels ... Cited by 200 - Related articles - BL Direct - All 5 versions
R Agusti, C Jordan, H Aste, F Tapia - Revista de investigación clínica; organo del Hospital … - ncbi.nlm.nih.gov 1: Rev Invest Clin. 1978 Oct-Dec;30(4):327-35. [Effect of hexanicotinate of
meso-inositol in patients with primary hyperlipidemia (author's transl)]. ... Cited by 4 - Related articles
A Goldberg… - The American Journal of Cardiology, 2000 - Elsevier This multicenter trial evaluated the safety and efficacy of escalating doses of
Niaspan (niacin extended-release tablets) and placebo (administered once-a-day
at bedtime) in patients with primary hyperlipidemia on the percent change ... Cited by 137 - Related articles - BL Direct - All 8 versions
GR Ziliotto, G Lamberti, A Wagner, L Cima, G … - Archivio per le scienze mediche - ncbi.nlm.nih.gov A cross-over trial was run to compare the effects of two delayed-action
nicotinic acid polyesters (pentaerythritol-tetranticotinate, PETN, and
inositol-hexanicotinate, MIEN) in 59 aged normo- and dyslipaemic subjects. ... Cited by 5 - Related articles
[CITATION] Diagnosis and treatment of dyslipidemia
J McKenney - American Journal of Health-System Pharmacy, 2003 - ASHP Abstract: The efficacy and safety profiles of various forms of niacin for
treating dyslip- idemia are described. Niacin is well recognized for treating
dys- lipidemia in adults and has been shown to be effective in reducing ... Cited by 36 - Related articles - BL Direct - All 7 versions
